Ferrari NV (RACE)vsWest Pharmaceutical Services Inc (WST)
RACE
Ferrari NV
$322.02
-2.17%
CONSUMER CYCLICAL · Cap: $60.04B
WST
West Pharmaceutical Services Inc
$245.27
+1.60%
HEALTHCARE · Cap: $17.09B
Smart Verdict
WallStSmart Research — data-driven comparison
Ferrari NV generates 130% more annual revenue ($7.08B vs $3.07B). RACE leads profitability with a 22.6% profit margin vs 16.1%. WST appears more attractively valued with a PEG of 2.89. WST earns a higher WallStSmart Score of 55/100 (C-).
RACE
Buy55
out of 100
Grade: C-
WST
Buy55
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-215.2%
Fair Value
$121.49
Current Price
$322.02
$200.53 premium
Margin of Safety
-257.4%
Fair Value
$68.88
Current Price
$245.27
$176.39 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 45 in profit
Large-cap with strong market position
Keeps 23 of every $100 in revenue as profit
Strong operational efficiency at 28.3%
Generating 1.4B in free cash flow
Safe zone — low bankruptcy risk
Strong operational efficiency at 21.6%
Areas to Watch
Premium valuation, high expectations priced in
Trading at 12.8x book value
2.9% earnings growth
Expensive relative to growth rate
Premium valuation, high expectations priced in
2.1% earnings growth
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : RACE
The strongest argument for RACE centers on Return on Equity, Market Cap, Profit Margin. Profitability is solid with margins at 22.6% and operating margin at 28.3%.
Bull Case : WST
The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.
Bear Case : RACE
The primary concerns for RACE are P/E Ratio, Price/Book, EPS Growth.
Bear Case : WST
The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.
Key Dynamics to Monitor
WST carries more volatility with a beta of 1.18 — expect wider price swings.
WST is growing revenue faster at 7.5% — sustainability is the question.
RACE generates stronger free cash flow (1.4B), providing more financial flexibility.
Monitor AUTO MANUFACTURERS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RACE scores higher overall (55/100 vs 55/100), backed by strong 22.6% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Ferrari NV
CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA
Ferrari NV designs, designs, produces and sells high performance sports cars. The company is headquartered in Maranello, Italy.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other AUTO MANUFACTURERS Stocks
Want to dig deeper into these stocks?